Skip to main content
. Author manuscript; available in PMC: 2022 Feb 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2021 Feb 1;86(2):157–163. doi: 10.1097/QAI.0000000000002536

Table 1:

Characteristics of Study Population

SM−
n=764
SM+
n=177
Age: median (IQR)a 30 (23 – 40) 30 (23 – 36)
Sex: n (%)a
Female 472 (61.8%) 95 (53.7%)
Male 292 (38.2%) 82 (46.3%)
Race: n (%)
Black African 764 (100%) 177 (100%)
Recruitment Site: n (%)a
Kisumu City (urban) 426 (59%) 103 (60%)
Kombewa (rural) 296 (41%) 68 (40%)
Hemoglobin g/dL: median (IQR)a 12.7 (11.4 – 13.9) 13·0 (11.7 – 14.1)
Pregnant: n (%)a 1 (0.23%) 0 (0%)
Malaria: n (%)a 2 (0.37%) 0 (0%)
Any Helminth (not including SM): n (%)a 77 (10.1%) 19 (10.7%)
Ascarisa 13 (1.7%) 1 (0.6%)
Trichurisa 16 (2.1%) 5 (2.8%)
Hookworma 52 (6.8%) 14 (7.9%)
Helminth Species (not including SM): n (%)a
0 687 (89.9%) 158 (89.3%)
1 73 (9.6%) 18 (10.2%)
2 4 (0.52%) 1 (0.56%)
SM Features
epg: median (IQR) NA 48 (24 – 144)
Light Intensity (1–99 epg): n (%) NA 122 (68.9%)
Moderate Intensity (100–399 epg): n (%) NA 41 (23.2%)
Heavy Intensity (400+ epg): n (%) NA 14 (7.9%)
HIV Features
Positive: n (%)a 301 (39.4%) 67 (37.9%)
Among Positive
Viral Load: median (IQR)a 30058 (1775 – 150 826) 18879 (2442 – 101 875)
Suppressed Viral Load: n (%) 25 (8.3%) 5 (7.5%)
CD4 Count (cells/μL): median (IQR) 395 (184 – 600) 467 (299 – 646)
On ART: n (%)
Yes 50 (16.6%) 6 (9.0%)
No 203 (67.5%) 55 (82.0%)
Unknown 48 (15.9%) 6 (9.0%)
Tuberculosis Features
QFT IFNγIU/mL (TB Antigen-Nil): median (IQR)
HC 0.00 (0.00 – 0.05) 0.00 (0.00 – 0.04)
LTBI 7.00 (2.12 – 9.57) 7.07 (1.76 – 9.53)
Abnormal Chest x-ray: n (%)
HC 3 (1.3%) 0 (0%)
LTBI 8 (2.5%) 2 (2.7%)
a

: Included in propensity score and outcome regression models.

Abbreviations: IQR, Interquartile Range; epg, Eggs Per Gram; QFT, QuantiFERON-TB Gold.